DePuy Synthes
| File:DePuy Synthes logo.svg | |
| Company type | Subsidiary |
|---|---|
| Industry | Template:Ublist |
| Founded | 1895 |
| Founders | Revra DePuy |
| Headquarters | 325 Paramount Drive, , U.S. |
Area served | Worldwide |
Key people | Michael M. Schulman (CFO) |
| Products | Replacement knees, hips, biomaterials |
| Parent | Johnson & Johnson Medtech |
| Website | depuysynthes |
DePuy Synthes () is a collection of orthopaedic and neurosurgical businesses operating as part of the Johnson & Johnson MedTech division, which was acquired by Johnson & Johnson in 1998. Its portfolio includes brands such as Codman, DePuy Mitek, DePuy Orthopaedics, and DePuy Spine.
The DePuy Orthopaedics segment is dedicated to the development, production, and distribution of joint replacement and trauma repair devices. Meanwhile, DePuy Spine concentrates on products for spinal fusion, correction of deformities, and bone fracture treatment.
With a presence spanning countries including the United Kingdom, Japan, France, Germany, Ireland, and Australia, DePuy serves as a vital component of Johnson & Johnson Medical’s operations across numerous international markets.
The company is currently involved in over 11,000 legal claims related to the recall of defective hip replacement implants, which could result in multi-billion dollar liabilities for Johnson & Johnson.
History
Established in 1895 by entrepreneur Revra DePuy in Warsaw, Indiana, the company’s initial innovation was creating fiber splints to substitute traditional wooden fracture supports.
In 2008, DePuy broadened its manufacturing capabilities by launching Johnson & Johnson Medical (Suzhou), Ltd. in China, thereby strengthening its global production network.
Following reports of elevated failure rates, DePuy initiated a recall in August 2010 for all ASR hip implant systems sold since 2003. This action led to widespread litigation accusing the company of design defects and insufficient safety warnings. Early court proceedings yielded varied outcomes with substantial damages awarded against the firm.
On June 14, 2012, Johnson & Johnson finalized the acquisition of Synthes and merged it with DePuy to create the DePuy Synthes Companies. This integration enhanced their product range and expanded their footprint in orthopaedics and trauma care markets.
In 2017, Codman Neurosurgery was divested to Integra LifeSciences for $1.045 billion as part of strategic portfolio realignment within the MedTech sector.
Most recently, on September 14, 2023, Johnson & Johnson consolidated its MedTech and pharmaceutical divisions under a unified Johnson & Johnson brand to simplify corporate structure and strengthen market positioning.
Operating companies
- Codman & Shurteff, Inc.
- DePuy Mitek, Inc.
- DePuy Orthopaedics, Inc.
- DePuy Spine, Inc.